PI3Kγ modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects

Cell

Volumn 118, Issue 3, 2004, Pages 375-387

  Patrucco, Enrico ^a   Notte, Antonella ^c   Barberis, Laura ^a   Selvetella, Giulio ^c   Maffei, Angelo ^c   Brancaccio, Mara ^a   Marengo, Stefano ^a   Russo, Giovanni ^c   Azzolino, Ornella ^a   Rybalkin, Sergei D ^d   Silengo, Lorenzo ^a,b   Altruda, Fiorella ^a,b   Wetzker, Reinhard ^e   Wymann, Matthias P ^f   Lembo, Giuseppe ^c,g   Hirsch, Emilio ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c IRCCS NEUROMED   (Italy)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e JENA UNIVERSITY HOSPITAL   (Germany)

^f UNIVERSITY OF BASEL   (Switzerland)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE III; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE GAMMA; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; GENE MUTATION; HEART; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; INFLAMMATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRESSURE; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; ENZYMOLOGY; GENETICS; HEART MUSCLE; HYPERTENSION; LEUKOCYTE; METABOLISM; PHYSIOLOGY;

ANIMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CELL MOVEMENT; CYCLIC AMP; HYPERTENSION; ISOENZYMES; LEUKOCYTES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 4344714889     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.07.017     Document Type: Article

References (36)

1. Alloatti G., Levi R., Malan D., Del Sorbo L., Bosco O., Barberis L., Marcantoni A., Bedendi I., Penna C., Azzolino O., et al. Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. Cardiovasc. Res. 60:2003;242-249
2. Antos C.L., Frey N., Marx S.O., Reiken S., Gaburjakova M., Richardson J.A., Marks A.R., Olson E.N. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ. Res. 89:2001;997-1004
3. Asai K., Yang G.P., Geng Y.J., Takagi G., Bishop S., Ishikawa Y., Shannon R.P., Wagner T.E., Vatner D.E., Homcy C.J., Vatner S.F. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. J. Clin. Invest. 104:1999;551-558
4. Beavo J.A. Cyclic nucleotide phosphodiesterases. functional implications of multiple isoforms Physiol. Rev. 75:1995;725-748
5. Bondeva T., Pirola L., Bulgarelli-Leva G., Rubio I., Wetzker R., Wymann M.P. Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science. 282:1998;293-296
6. Brancaccio M., Fratta L., Notte A., Hirsch E., Poulet R., Guazzone S., De Acetis M., Vecchione C., Marino G., Altruda F., et al. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat. Med. 9:2003;68-75
7. Brede M., Wiesmann F., Jahns R., Hadamek K., Arnolt C., Neubauer S., Lohse M.J., Hein L. Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation. 106:2002;2491-2496
8. Bueno O.F., Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91:2002;776-781
9. Cantley L.C. The phosphoinositide 3-kinase pathway. Science. 296:2002;1655-1657
10. Crackower M.A., Oudit G.Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., Hirsch E., Suzuki A., Shioi T., Irie-Sasaki J., et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell. 110:2002;737-749
11. Engelhardt S., Hein L., Wiesmann F., Lohse M.J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 96:1999;7059-7064
12. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 287:2000;1049-1053
13. Iwase M., Bishop S.P., Uechi M., Vatner D.E., Shannon R.P., Kudej R.K., Wight D.C., Wagner T.E., Ishikawa Y., Homcy C.J., Vatner S.F. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ. Res. 78:1996;517-524
14. Kitamura T., Kitamura Y., Kuroda S., Hino Y., Ando M., Kotani K., Konishi H., Matsuzaki H., Kikkawa U., Ogawa W., Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19:1999;6286-6296
15. Liao P., Georgakopoulos D., Kovacs A., Zheng M., Lerner D., Pu H., Saffitz J., Chien K., Xiao R.P., Kass D.A., Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. USA. 98:2001;12283-12288
16. Manabe I., Shindo T., Nagai R. Gene expression in fibroblasts and fibrosis. involvement in cardiac hypertrophy Circ. Res. 91:2002;1103-1113
17. Matsui T., Li L., Wu J.C., Cook S.A., Nagoshi T., Picard M.H., Liao R., Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277:2002;22896-22901
18. Movsesian M.A. PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes. Basic Res. Cardiol. Suppl. 97:2002;I83-I90
19. Naga Prasad S.V., Esposito G., Mao L., Koch W.J., Rockman H.A. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J. Biol. Chem. 275:2000;4693-4698
20. Naga Prasad S.V., Laporte S.A., Chamberlain D., Caron M.G., Barak L., Rockman H.A. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J. Cell Biol. 158:2002;563-575
21. Nienaber J.J., Tachibana H., Naga Prasad S.V., Esposito G., Wu D., Mao L., Rockman H.A. Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J. Clin. Invest. 112:2003;1067-1079
22. Oudit G.Y., Crackower M.A., Eriksson U., Sarao R., Kozieradzki I., Sasaki T., Irie-Sasaki J., Gidrewicz D., Rybin V.O., Wada T., et al. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation. 108:2003;2147-2152. Published online September 8, 2003.
23. Prasad S.V., Perrino C., Rockman H.A. Role of phosphoinositide 3-kinase in cardiac function and heart failure. Trends Cardiovasc. Med. 13:2003;206-212
24. Rapacciuolo A., Esposito G., Caron K., Mao L., Thomas S.A., Rockman H.A. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J. Am. Coll. Cardiol. 38:2001;876-882
25. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature. 415:2002;206-212
26. Rondinone C.M., Carvalho E., Rahn T., Manganiello V.C., Degerman E., Smith U.P. Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor. J. Biol. Chem. 275:2000;10093-10098
27. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., Cantley L.C., Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19:2000;2537-2548
28. Stephens L.R., Eguinoa A., Erdjument-Bromage H., Lui M., Cooke F., Coadwell J., Smrcka A.S., Thelen M., Cadwallader K., Tempst P., Hawkins P.T. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell. 89:1997;105-114
29. Stoyanov B., Volinia S., Hanck T., Rubio I., Loubtchenkov M., Malek D., Stoyanova S., Vanhaesebroeck B., Dhand R., Nurnberg B., et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science. 269:1995;690-693
30. Stoyanova S., Bulgarelli-Leva G., Kirsch C., Hanck T., Klinger R., Wetzker R., Wymann M.P. Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase gamma. structure-activity analysis and interactions with wortmannin Biochem. J. 324:1997;489-495
31. Thompson W.J., Appleman M.M. Characterization of cyclic nucleotide phosphodiesterases of rat tissues. J. Biol. Chem. 246:1971;3145-3150
32. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:2001;535-602
33. Wymann M.P., Bjorklof K., Calvez R., Finan P., Thomast M., Trifilieff A., Barbier M., Altruda F., Hirsch E., Laffargue M. Phosphoinositide 3-kinase gamma. a key modulator in inflammation and allergy Biochem. Soc. Trans. 31:2003;275-280. a
34. Wymann M.P., Zvelebil M., Laffargue M. Phosphoinositide 3-kinase signalling - which way to target? Trends Pharmacol. Sci. 24:2003;366-376. b
35. Zhang D., Gaussin V., Taffet G.E., Belaguli N.S., Yamada M., Schwartz R.J., Michael L.H., Overbeek P.A., Schneider M.D. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6:2000;556-563
36. Zhang S., Weinheimer C., Courtois M., Kovacs A., Zhang C.E., Cheng A.M., Wang Y., Muslin A.J. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest. 111:2003;833-841